Detalhe da pesquisa
1.
Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma.
Blood
; 132(24): 2555-2563, 2018 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30282798
2.
VTD is superior to VCD prior to intensive therapy in multiple myeloma: results of the prospective IFM2013-04 trial.
Blood
; 127(21): 2569-74, 2016 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27002117
3.
Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma.
Ann Hematol
; 97(5): 831-837, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29330561
4.
Pomalidomide plus low-dose dexamethasone in multiple myeloma with deletion 17p and/or translocation (4;14): IFM 2010-02 trial results.
Blood
; 125(9): 1411-7, 2015 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25575538
5.
Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patients.
Haematologica
; 99(7): 1236-8, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24727820
6.
Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma.
Blood
; 118(22): 5752-8; quiz 5982, 2011 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21849487
7.
Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials.
Haematologica
; 98(1): 87-94, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22875621
8.
Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive Study.
Cancers (Basel)
; 11(9)2019 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31500210
9.
Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome.
J Clin Oncol
; 34(18): 2125-32, 2016 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27114594
10.
Effects of long-term intravenous ibandronate therapy on skeletal-related events, survival, and bone resorption markers in patients with advanced multiple myeloma.
J Clin Oncol
; 20(9): 2353-9, 2002 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11981007
11.
Karyotypic abnormalities in myelofibrosis following polycythemia vera.
Cancer Genet Cytogenet
; 140(2): 118-23, 2003 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12645649
12.
Chromosomal abnormalities are major prognostic factors in elderly patients with multiple myeloma: the intergroupe francophone du myélome experience.
J Clin Oncol
; 31(22): 2806-9, 2013 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23796999
13.
The translocation t(4;14) can be present only in minor subclones in multiple myeloma.
Clin Cancer Res
; 19(17): 4634-7, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23857603
14.
Long-term analysis of the IFM 99 trials for myeloma: cytogenetic abnormalities [t(4;14), del(17p), 1q gains] play a major role in defining long-term survival.
J Clin Oncol
; 30(16): 1949-52, 2012 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22547600
15.
[Avascular osteonecrosis of the jaws induced by diphosphonates]. / Ostéonécrose avasculaire de la machoire sous diphosphonates.
Therapie
; 61(4): 363-5, 2006.
Artigo
em Francês
| MEDLINE | ID: mdl-17124954
16.
Bortezomib plus dexamethasone induction improves outcome of patients with t(4;14) myeloma but not outcome of patients with del(17p).
J Clin Oncol
; 28(30): 4630-4, 2010 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20644101
17.
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome.
Blood
; 109(8): 3489-95, 2007 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17209057
18.
Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy.
Blood
; 107(4): 1292-8, 2006 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16174762
19.
Alpha-interferon in combination with cytarabine in children with Philadelphia chromosome-positive chronic myeloid leukemia.
J Pediatr Hematol Oncol
; 24(1): 18-22, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11902732